Royalty Pharma
RPRX
#1045
Rank
HK$141.00 B
Marketcap
HK$239.33
Share price
-0.65%
Change (1 day)
4.71%
Change (1 year)

Royalty Pharma (RPRX) - Cash on Hand

Cash on Hand as of September 2024 : HK$13.73 Billion

According to Royalty Pharma's latest financial reports the company has HK$13.73 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Royalty Pharma - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$9.63 B-49.2%
2022-12-31HK$18.96 B-13.22%
2021-12-31HK$21.85 B6.44%
2020-12-31HK$20.53 B232.43%
2019-12-31HK$6.17 B-66.94%
2018-12-31HK$18.68 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$1.19 B-91.31%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$60.61 B 341.42%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.38 B 99.42%๐Ÿ‡บ๐Ÿ‡ธ USA